ID PC-3M AC CVCL_9555 SY PC3-M; PC-3/M; PC3M; Pc3M DR BTO; BTO_0005220 DR EFO; EFO_0022442 DR cancercelllines; CVCL_9555 DR ChEMBL-Cells; CHEMBL4295486 DR ChEMBL-Targets; CHEMBL4296484 DR CLS; 305061 DR Cosmic; 1945877 DR GEO; GSM1178559 DR GEO; GSM1178560 DR GEO; GSM1178561 DR KCLB; 80020 DR KYinno; KC-3937 DR NCI-DTP; PC-3/M DR PubChem_Cell_line; CVCL_9555 DR TOKU-E; 3851 DR Wikidata; Q54938435 RX PubMed=447482; RX PubMed=3335022; RX PubMed=7017212; RX PubMed=7471073; CC Population: Caucasian. CC Characteristics: Established from a xenografted tumor of nude mice injected with the parent cell line (PubMed=447482). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line). CC Omics: Transcriptomics; Microarray. CC Derived from site: Metastatic; Bone; UBERON=UBERON_0002481. ST Source(s): KCLB=80020 ST Amelogenin: X ST CSF1PO: 11 ST D13S317: 11 ST D3S1358: 16 ST D5S818: 13 ST D7S820: 8,11 ST FGA: 24 ST TH01: 6,7 ST TPOX: 8,9 ST vWA: 17 DI NCIt; C4863; Prostate carcinoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) HI CVCL_0035 ! PC-3 SX Male AG 62Y CA Cancer cell line DT Created: 06-06-12; Last updated: 14-08-25; Version: 30 CH CVCL_5J43 ! hVEGF-luc/PC3M CH CVCL_6E87 ! PC-3/MA2 CH CVCL_G257 ! PC-3M-1E8 CH CVCL_G256 ! PC-3M-2B4 CH CVCL_L155 ! PC-3M-LN1 CH CVCL_D577 ! PC-3M-luc-C6 CH CVCL_5J25 ! PC-3M-luc2 CH CVCL_L158 ! PC-3M-Pro1 CH CVCL_5J10 ! PC-3M-Red-FLuc CH CVCL_4885 ! PC3-MM2 // RX PubMed=3335022; RA Alley, Michael C. RA Scudiero, Dominic A. RA Monks, Anne RA Hursey, Miriam L. RA Czerwinski, Maciej J. RA Fine, Donald L. RA Abbott, Betty Jane RA Mayo, Joseph G. RA Shoemaker, Robert H. RA Boyd, Michael R. RT "Feasibility of drug screening with panels of human tumor cell lines RT using a microculture tetrazolium assay."; RL Cancer Res. 48:589-601(1988). // RX PubMed=7471073; RA Ohnuki, Yasushi RA Marnell, Maureen M. RA Babcock, Merrill S. RA Lechner, John F. RA Kaighn, M. Edward RT "Chromosomal analysis of human prostatic adenocarcinoma cell lines."; RL Cancer Res. 40:524-534(1980). // RX PubMed=447482; RA Kaighn, M. Edward RA Narayan, K. Shankar RA Ohnuki, Yasushi RA Lechner, John F. RA Jones, Lawrence W. RT "Establishment and characterization of a human prostatic carcinoma RT cell line (PC-3)."; RL Invest. Urol. 17:16-23(1979). // RX PubMed=7017212; DOI=10.1093/jnci/66.6.1003; RA Pollack, Marilyn S. RA Heagney, Socorro D. RA Livingston, Philip O. RA Fogh, Jorgen RT "HLA-A, B, C and DR alloantigen expression on forty-six cultured human RT tumor cell lines."; RL J. Natl. Cancer Inst. 66:1003-1012(1981). //